754PEffect of second-line cabozantinib on health states for patients with advanced hepatocellular carcinoma (aHCC) after sorafenib: QTWiST analysis from the CELESTIAL studyN Freemantle,G K Abou-Alfa,A-L Cheng,R K Kelley, V Valcheva, F Benzaghou, P MollonANNALS OF ONCOLOGY（2019）引用 8|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
